ArticleDrug design, development and therapy2023

Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis.

Xuehui Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.